Clinical Profile and middle cerebral artery velocity of children with sickle cell anaemia seen in UUTH, Uyo, Akwa Ibom state, Nigeria.
Main Article Content
Keywords
Sickle Cell Anaemia, Middle Cerebral Artery Velocity, Transcranial Doppler Ultrasonography, Stroke, Children
Abstract
Background: The risk of stroke in individuals with Sickle Cell Anaemia (SCA) can be assessed by routine non-invasive measurement of their cerebral blood flow using a Transcranial Doppler (TCD) ultrasound scan. This study aimed to determine the difference in blood flow velocity parameters in the middle cerebral artery (MCA) of children with sickle cell anaemia compared to a normal age-matched population.
Methodology: This was a hospital-based comparative cross-sectional study among 40 SCA patients aged 3-16 years, in steady state and 40 age and sex-matched HbAA healthy subjects. This study lasted from June to October 2019. Medical history was retrieved using a structured questionnaire. The time-averaged mean of maximum velocity (TAMMV) of the right and left MCA was measured using non-imaging TCD.
Results: The mean age ± SD of the SCA patients was 9.1 ± 4.4 years. The SCA patients and sex and age-matched HbAA group consisted of 23 (57.5%) males and 17 (42.5%) females respectively. SCA patients had a significantly lower mean ± SD haemoglobin (Hb) than the controls (7.1 ± 1.1g/dl and 11.1 ± 1.4g/dl; p<0.001). The right MCA of the patients with SCA had a significantly higher mean flow velocity compared to the controls (94.1 ± 23.1 vs 55.0 ± 8.8cm/sec, p<0.001).
Conclusion: The mean TAMMV recorded in the SCA subjects were significantly higher than that of the non-SCA subjects. There is a need to ensure that TCD ultrasound is employed as a routine screening tool for stroke risk among SCA patients in Nigerian tertiary health institutions.
References
2. Kaine W, Udeozo I. Incidence of sickle-cell trait and anaemia in Ibo pre-school children. Nigerian Journal of Paediatrics. 1981;8(4):87-9.
3. Chinawa JM, Chinawa AT, Ossai EN, Chukwu BF, Ndu IK, Asinobi IN. Left ventricular function and cardiac valvar annular dimensions among children with sickle cell anemia compared to those with hemoglobin AA type in Enugu, Nigeria. Malawi Medical Journal. 2021;33(2):127-34.
4. Chinawa JM, Chukwu BF, Chinawa AT, Ossai EN, Ikefuna AN, Aronu AE, et al. Right ventricular function among South East Nigeria children with sickle cell anaemia. BMC pediatrics. 2020;20:1-9.
5. Umoh AV, Abah GM, Ekanem TI, Essien EM. Haemoglobin Genotypes: A Prevalence Study and Implications for Reproductive Health in Uyo, Nigeria. Nigerian Journal of Medicine. 2010;19(1):36-41.
6. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, et al. Cerebrovascular Accidents in Sickle Cell Disease: Rates and Risk Factors. Blood. 1998;91(1):288-94.
7. Ware RE, Zimmerman SA, Schultz WH. Hydroxyurea as an Alternative to Blood Transfusions for the Prevention of Recurrent Stroke in Children With Sickle Cell Disease. Blood. 1999;94(9):3022-6.
8. Abdullahi SU, DeBaun MR, Jordan LC, Rodeghier M, Galadanci NA. Stroke Recurrence in Nigerian Children With Sickle Cell Disease: Evidence for a Secondary Stroke Prevention Trial. Pediatr Neurol. 2019;95:73-8.
9. George I, Frank-Briggs A. Stroke in Nigerian children with sickle cell anaemia. Journal of Public health and Epidemiology. 2011;3(9):407-9.
10. Kirkham FJ, Lagunju IA. Epidemiology of Stroke in Sickle Cell Disease. J Clin Med J Clin Med. 2021 Sep 18;10(18):4232. doi: 10.3390/jcm10184232.
11. Fatunde O, Adamson F, Ogunseyinde O, Sodeinde O, Familusi J. Stroke in Nigerian children with sickle cell disease. African journal of medicine and medical sciences. 2005;34(2):157-60.
12. Hebbel RP, Vercellotti GM. The endothelial biology of sickle cell disease. Journal of Laboratory and Clinical Medicine. 1997;129(3):288-93.
13. Phelan MW, Faller DV. Hypoxia decreases constitutive nitric oxide synthase transcript and protein in cultured endothelial cells. Journal of cellular physiology. 1996;167(3):469-76.
14. Hoppe C. Defining stroke risk in children with sickle cell anaemia. British journal of haematology. 2005;128(6):751-66.
15. Ferster A, Tahriri P, Vermylen C, Sturbois G, Corazza F, Fondu P, et al. Five years of experience with hydroxyurea in children and young adults with sickle cell disease. Blood, The Journal of the American Society of Hematology. 2001;97(11):3628-32.
16. Ismail WIM, Elnour M, Mustafa AEM. Evaluation of transcranial Doppler abnormalities in children with sickle cell disease in El-Obeid Specialized Children's Hospital. Journal of Family Medicine and Primary Care. 2019;8(3):1176-81.
17. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. New England Journal of Medicine. 1998;339(1):5-11.
18. Adams RJ, Aaslid R, El Gammal T, Nichols FT, McKie V. Detection of cerebral vasculopathy in sickle cell disease using transcranial Doppler ultrasonography and magnetic resonance imaging. Case report. Stroke. 1988;19(4):518-20.
19. Krejza J, Rudzinski W, Pawlak M, Tomaszewski M, Ichord R, Kwiatkowski J, et al. Angle-corrected imaging transcranial doppler sonography versus imaging and nonimaging transcranial doppler sonography in children with sickle cell disease. American journal of neuroradiology. 2007;28(8):1613-8.
20. Zétola VF. Role of TCD in sickle cell disease: A review. Perspectives in Medicine. 2012;1(1-12):265-8.
21. Adams RJ, Nichols FT, Figueroa R, McKie V, Lott T. Transcranial Doppler correlation with cerebral angiography in sickle cell disease. Stroke. 1992;23(8):1073-7.
22. Adams RJ, McKie VC, Brambilla D, Carl E, Gallagher D, Nichols FT, et al. Stroke prevention trial in sickle cell anemia. Controlled clinical trials. 1998;19(1):110-29.
23. Nichols FT, Jones AM, Adams RJ. Stroke Prevention in Sickle Cell Disease (STOP) Study Guidelines for Transcranial Doppler Testing. Journal of Neuroimaging. 2001;11(4):354-62.
24. Lagunju I, Sodeinde O, Telfer P. Prevalence of transcranial Doppler abnormalities in Nigerian children with sickle cell disease. American journal of hematology. 2012;87(5):544-7.
25. Soyebi K, Adeyemo T, Ojewunmi O, James F, Adefalujo K, Akinyanju O. Capacity building and stroke risk assessment in Nigerian children with sickle cell anaemia. Pediatric Blood & Cancer. 2014;61(12):2263-6.
26. Adekunle MO, Animasahun AB, Diaku-Akinwumi IN, Njokanma OF. Pattern of cerebral blood flow velocity using transcranial doppler ultrasonography in children with sickle cell disorder in Lagos state, Nigeria. Mediterranean journal of hematology and infectious diseases. 2017;9(1).
27. Charan J, Biswas T. How to calculate sample size for different study designs in medical research? Indian journal of psychological medicine. 2013;35(2):121-6.
28. Akinyanju OO. A profile of sickle cell disease in Nigeria. Annals of the New York Academy of Sciences. 1989;565:126-36.
29. Stephen N, Nden N, Gusen NJ, Kumzhi PR, Gaknung B, Auta DA, et al. Prevalence of sickle cell disease among children attending plateau specialist hospital, Jos, Nigeria. Acta Medica International. 2018;5(1):20-3.
30. Ismail A, Yusuf AA, Kuliya-Gwarzo A, Ahmed SG, Tabari AM, Abubakar SA. Correlating transcranial arterial Doppler velocities with haematologic parameters and haemolytic indices of Nigerian children with sickle cell anaemia. Ultrasound. 2019;27(2):101-10.
31. Mbamognoua NGA, Edzan JC, Mawa FOE, Kambourou J, Ngolet LO, Monabeka HG. Correlation between Pubertal Delay in Adolescents with Homozygous Sickle Cell Disease and Socio-Demographic, Clinical Factors. Open Journal of Endocrine and Metabolic Diseases. 2023;13(10):173-90.
32. Strouse J. Sickle cell disease. Handbook of clinical neurology. 2016;138:311-24.
33. Makani J, Kirkham FJ, Komba A, Ajala‐Agbo T, Otieno G, Fegan G, et al. Risk factors for high cerebral blood flow velocity and death in Kenyan children with Sickle Cell Anaemia: role of haemoglobin oxygen saturation and febrile illness. British journal of haematology. 2009;145(4):529-32.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.